Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P575 Real-world effectiveness and safety of ustekinumab for the treatment of refractory Crohn’s disease: The Scottish ustekinumab cohort

ECCO'20 Vienna

Year: 2020
Authors:

N. PLEVRIS1, A. Robertson2, J. Fulforth1, R. Hall3, I. Campbell4, C. Kane5, J. Veryan6, W. Lam6, J. Saunders2, P. Jenkinson1, C. Chuah7, C. Kelly8, D. Watts8, D. Gaya6, J. Macdonald9, H. Jafferbhoy7, J.P. Seenan9, C. Mowat3, D. Sutherland2, G. Naismith10, G. Bain5, I. Arnott1, G. Jones1, C. Lees1

1Department of Gastroenterology, Western General Hospital, The Edinburgh IBD Unit, Edinburgh, UK, 2Department of Gastroenterology, University Hospital Hairmyres, Glasgow, UK, 3Department of Gastroenterology, Ninewells Hospital, Dundee, UK, 4Department of Gastroenterology, Royal Alexandra Hospital, Glasgow, UK, 5Department of Gastroenterology, Aberdeen Royal Infirmary, Aberdeen, UK, 6Department of Gastroenterology, Glasgow Royal Infirmary,Glasgow, UK, 7Department of Gastroenterology, Victoria Hospital, Kirkcaldy, UK, 8Department of Gastroenterology, Forth Valley Royal Hospital, Larbert, UK, 9Department of Gastroenterology, Queen Elizabeth University Hospital, Glasgow, UK, 10Department of Gastroenterology, Royal Alexandra Hospital, Paisley, UK

P576 The value of small bowel capsule endoscopy in the change of therapeutic management in patients with established Crohn’s disease

ECCO'20 Vienna

Year: 2020
Authors:

N. Viazis1, E. Tsoukali1, C. Pontas1, G. Karampekos1, F. Gkeros1, G. Filippidis1, M. Vraka1, K. Koustenis1, K. Mountaki1, I. Mitselos2, M. Mela1, A. Christidou1, E. Archavlis1, E. Vienna1, D. Christodoulou2, G. Mantzaris1

1Evangelismos Hospital, Department of Gastroenterology, Athens, Greece, 2University Hospital and Medical School of Ioannina, Gastroenterology, Ioannina, Greece

P577 Ustekinumab in actual clinical practice: our centre experience

ECCO'20 Vienna

Year: 2020
Authors:

J.M. LOPEZ TOBARUELA, A.D. Sanchez-Capilla, E.J. Ortega-Suazo, M.C. Fernandez-Cano, M. Herrador-Paredes, M.J. Cabello-Tapia, M.M. Martin-Rodriguez

Hospital Universitario Virgen de las Nieves, Gastroenterology, Granada, Spain

P578 Inter-observer agreement of an expert panel for gastrointestinal ultrasound in ulcerative colitis

ECCO'20 Vienna

Year: 2020
Authors:

F. de Voogd1, R. Wilkens2, K. Gecse1, M. Allocca3, K. Novak4, C. Lu4, G. D’Haens1, C. Maaser5, International Bowel UltraSound (IBUS) - Group

1Amsterdam University Medical Centers, Departmenn of Gastroenterology and Hepatology, Amsterdam, The Netherlands, 2Hvidovre Hospital, Gastrounit- Division of Medicine, Copenhagen, Denmark, 3Humanitas University, Gastroenterology, Milan, Italy, 4University of Calgary, Medicine- Division of Gastroenterology, Calgary, Canada, 5University Teaching Hospital Lueneburg, Gastroenterology, Lueneburg, Germany

P579 Randomised open-label controlled trial of ciprofloxacin/doxycycline/hydroxychloroquine combination compared with standard budesonide in active Crohn’s disease (APRICOT)

ECCO'20 Vienna

Year: 2020
Authors:

J.M. Rhodes1, S. Subramanian2, P. Flanagan3, G. Horgan4, K. Martin2, J. Mansfield5, M. Parkes6, A. Hart7, H. Dallal8, T. Iqbal9, J. Butterworth10, K. Culshaw11, C. Probert1

1University of Liverpool, Institute of Translational Medicine, Liverpool- UK, UK, 2Royal Liverpool University Hospitals Trust, Gastroenterology, Liverpool, UK, 3Wirral University Teaching Hospital NHS Foundation Trust, Gastroenterology, Wirral, UK, 4Rowett Institute of Nutrition and Health, Biomathematics and Statistics Scotland, Aberdeen, UK, 5Newcastle upon Tyne Hospitals NHS Foundation Trust, Gastroenterology, Newcastle upon Tyne, UK, 6Cambridge University Hospitals NHS Foundation Trust, Gastroenterology, Cambridge, UK, 7St Mark’s Hospital- Harrow, Gastroenterology, London, UK, 8James Cook University Hospital, Gastroenterology, Middlesbrough, UK, 9Queen Elizabeth Hospital Birmingham NHS Foundation Trust, Gastroenterology, Birmingham, UK, 10Shrewsbury and Telford Hospital NHS Trust, Gastroenterology, Shrewsbury, UK, 11University of Liverpool, Liverpool Cancer Trials Unit, Liverpool, UK

P580 Irritable bowel syndrome in inflammatory bowel disease after remission: correlation with remission patterns and inflammation

ECCO'20 Vienna

Year: 2020
Authors:

O. Sezgin1, B. Boztepe2, E. Altintas1, D. Çelikcan3

1Mersin University Faculty of Medicine, Gastroenterology, Mersin, Turkey, 2Didim State Hospital, İnternal Medicine, Aydın, Turkey, 3Mersin University Faculty of Medicine, Biostatistics, Mersin, Turkey

P581 Allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulas in Crohn’s disease: First real-life experiences

ECCO'20 Vienna

Year: 2020
Authors:

P.O. Schreiner1, L. Biedermann1, G. Rogler1, M. Turina2, D. Cabalzar2

1University Hospital Zurich, Department of Gastroenterology and Hepatology, Zurich, Switzerland, 2University Hospital Zurich, Department of Surgery and Transplantation, Zurich, Switzerland

P582 Adalimumab therapeutic drug monitoring: Does time of testing matter?

ECCO'20 Vienna

Year: 2020
Authors:

S. Shields1, J.P. Seenan1, A. Dunlop2, P. Galloway2, J. Macdonald1

1Department of Gastroenterology, Queen Elizabeth University Hospital, Glasgow, UK, 2Department of Biochemistry, Queen Elizabeth University Hospital, Glasgow, UK

P583 The prevalence of side effects to immunomodulators and biologics in patients with Crohn’s disease intestinal failure compared with Crohn’s disease without intestinal failure

ECCO'20 Vienna

Year: 2020
Authors:

S. Bouri1, J. Geldof1, J. Willsmore2, S. Donnelly2, S. Gabe2, A. Hart1

1St Mark’s Hospital, IBD Unit, London, UK, 2St Mark’s Hospital, Intestinal Failure, London, UK

P584 Use of mycophenolate mofetil in inflammatory bowel disease: results from the ENEIDA registry

ECCO'20 Vienna

Year: 2020
Authors:

A. Hernandez Camba1, L. Arranz1, I. Vera2, D. Carpio3, M. Calafat Sard4, A. Lucendo5, C. Taxonera6, S. Marín7, M.J. Garcia8, G. Suris Marín9, E. Sánchez Rodríguez10, A.Y. Carbajo11, M.L. De Castro12, M. Iborra13, A. Martin-Cardona14, I. Rodríguez Lago15, D. Busquets16, F. Bertoletti17, M. Sierra Ausín18, C. Tardillo1, J. Huguet Malaves19, L. Bujanda20, A. Castaño21, O. Merino22, E. Domènch23, L. Ramos24, ENEIDA Project of GETECCU

1Hosp. Universitario Nuestra Señora de la Candelaria, Gastroenterology, Santa Cruz de Tenerife, Spain, 2Hospital Universitario Puerta de Hierro, Gastroenterology, Madrid, Spain, 3Complexo Hospitalario Universitario de Pontevedra, Gastroenterology, Pontevedra, Spain, 4Hospital Universitario Germans Trias i Pujol, Gastroenterology, Badalona, Spain, 5Hospital General de Tomelloso, Gastroenterology, Tomelloso, Spain, 6Hospital Clínico San Carlos, Gastroenterology, Madrid, Spain, 7Hospital Reina Sofía, Gastroenterology, Córdoba, Spain, 8Hospital Universitario Marqués de Valdecilla, Gastroenterology, Santander, Spain, 9Hospital Universitari de Bellvitge, Gastroenterology, Barcelona, Spain, 10Hospital Universitario Ramón y Cajal, Gastroenterology, Madrid, Spain, 11Hospital Universitario Río Hortega, Gastroenterology, Valladolid, Spain, 12Complexo H. Universitario de Vigo, Gastroenterology, Vigo, Spain, 13Hospital Universitari La Fe de Valencia and CIBEREHD, Gastroenterology, Valencia, Spain, 14Hospital Universitari Mútua Terrassa and CIBEREHD, Gastroenterology, Barcelona, Spain, 15Hospital de Galdakao, Gastroenterology, Galdakao, Spain, 16Hospital Universitari de Girona, Gastroenterology, Girona, Spain, 17Hospital de la Sta Creu i Sant Pau, Gastroenterology, Barcelona, Spain, 18Complejo Asistencial Universitario de León, Gastroenterology, León, Spain, 19Hospital General Universitario de Valencia, Gastroenterology, Valencia, Spain, 20Hospital Universitario de Donostia- Instituto Biodonostia- Universidad del País Vasco UPV/EHU- and CIBEREHD, Gastroenterology, Donostia, Spain, 21Hospital Universitario Central de Asturias, Gastroenterology, Oviedo, Spain, 22Hospital de Cruces, Gastroenterology, Barakaldo, Spain, 23Hospital Universitario Germans Trias i Pujol and CIBEREHD, Gastroenterology, Badalona, Spain, 24Hospital Universitario de Canarias, Gastroenterology, La Laguna, Spain

P585 Evaluation and comparison of the safety profiles of different intravenous iron preparations and oral iron for treatment of iron deficiency anaemia: Preliminary results from the IBD subgroup analysis

ECCO'20 Vienna

Year: 2020
Authors:

A. Aksan1,2,3, H. Işık4, S. Aksan2, D. Tuğal5, A. Dignass6, J.M. Stein2,3,7

1Justus-Liebig-Universität, Institute of Nutritional Science, Giessen, Germany, 2Interdisciplinary Crohn-Colitis Centre Rhein-Main, Clinical and Scientific Research, Frankfurt am Main, Germany, 3J.W. Goethe University, Institute of Pharmaceutical Chemistry, Frankfurt am Main, Germany, 4Hacettepe University, Institute of Science, Ankara, Turkey, 5Hacettepe University, Institute of Nutritional Science, Ankara, Turkey, 6Agaplesion Markus Krankenhaus, Gastroenterology, Frankfurt am Main, Germany, 7DGD Clinics Sachsenhausen, Gastroenterology and Clinical Nutrition, Frankfurt am Main, Germany

P586 Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease

ECCO'20 Vienna

Year: 2020
Authors:

B. GU1, K. Venkatesh2, A.J. Williams3, W. Ng3, C. Corte4, S. Ghaly2, W. Xuan5, S. Paramsothy6, S. Connor3

1University of New South Wales, South Western Sydney Clinical School, Sydney, Australia, 2St Vincent’s Hospital, Department of Gastroenterology and Hepatology, Sydney, Australia, 3Liverpool Hospital, Department of Gastroenterology and Hepatology, Sydney, Australia, 4Royal Prince Alfred Hospital, Department of Gastroenterology and Hepatology, Sydney, Australia, 5Ingham Institute for Applied Medical Research, South Western Sydney Clinical School, Sydney, Australia, 6Concord Repatriation General Hospital, Department of Gastroenterology and Hepatology, Sydney, Australia

P587 Adalimumab in pediatric Crohn’s disease: A long-term multi-centre real-world experience

ECCO'20 Vienna

Year: 2020
Authors:

S. Lawrence1, H. Huynh2, W. El-Matary3, J. DeBruyn4, M. Carroll2, E. Wine2, J. Chan1, K. Jacobson1

1University of British Columbia, Department of Pediatric Gastroenterology, Vancouver, Canada, 2University of Alberta, Department of Pediatric Gastroenterology, Edmonton, Canada, 3University of Manitoba, Department of Pediatric Gastroenterology, Winnipeg, Canada, 4University of Calgary, Section of Pediatric Gastroenterology, Calgary, Canada

P588 vedolizumab trough levels at week 6 and 14 correlate with clinical remission in inflammatory bowel disease patients

ECCO'20 Vienna

Year: 2020
Authors:

M. Marino1, R. Domenis2, L. Biribin1, A. Cifù2, L. Navarria1, G. Scardino1, M. Fabris2

1Department of Gastroenterology, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy, 2Istituto di Patologia Clinica, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy

P589 Longer-term outcomes in patients with Crohn’s disease who are primary non-responders to anti-TNF in a single UK centre

ECCO'20 Vienna

Year: 2020
Authors:

P. HODGES, J. Saunders, F. Betteridge

Department of Gastroenterology, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK

P590 Outcomes of patients treated with sequential anti-TNF therapy in a tertiary referral centre

ECCO'20 Vienna

Year: 2020
Authors:

C. Rowan, J. O’Donnell, N. Cullen, A. O’Toole, K. Boland

Beaumont Hospital, Department of Gastroenterology, Dublin, Ireland

P591 Therapeutic management in inflammatory bowel disease: Differences in two IBD inception cohorts: 1991–93 and 2010–11 enrolled in the north-west of Spain

ECCO'20 Vienna

Year: 2020
Authors:

M.L. De Castro Parga, V. Hernández, L. Sanroman, J.R. Pineda, M. Figueira, J. Martinez-Cadilla, S. Pereira, J.I. Rodriguez-Prada

University Hospital Complex of Vigo, Department of Gastroenterology, Vigo, Spain

P592 Frequency and causes of prolongation of the induction course of tofacitinib in patients with ulcerative colitis in conditions of real clinical practice

ECCO'20 Vienna

Year: 2020
Authors:

O. Knyazev, A. Kagramanova, A. Lishchinskaya, A. Parfenov

Moscow Scientific Center named after A. S. Loginov, Department of IBD, Moscow, Russian Federation

P593 Predictors of steroid-resistance in severe colitis of inflammatory bowel disease

ECCO'20 Vienna

Year: 2020
Authors:

C. JEMMALI1, A. Labidi2, M.A. Jouini2, M. Hafi2, M. Serghini2, M. Fekih2, J. Boubaker2

1Faculty of Medicine of Tunis, Gastroenterology A Rabta, Tunis, Tunisia, 2Rabta, Gastroenterology A, Tunis, Tunisia

P594 Increased levels of stress, anxiety and depression among patients with CD and UC

ECCO'20 Vienna

Year: 2020
Authors:

E. Laoudi1, D. Papalouka2, M. Gkizis1, G. Kokkotis1, N. Perlepe1, I. Vlachogiannakos3, I. Papakonstantinou2, G. Bamias1

1National and Kapodistrian University of Athens, GI Unit-3rd Academic Department of Internal Medicine- Sotiria Hospital, Athens, Greece, 2Medical School-National and Kapodistrian University of Athens, 2nd Department of Surgery Aretaieion Hospital, Athens, Greece, 3National and Kapodistrian University of Athens- Medical School, Gastroenterology Department of Laiko Hospital, Athens, Greece